Previous extensive evaluations of commercial measles IgM EIA kits resulted in the broad adoption of the Siemens (previously Behring) Enzygnost kit within the WHO global measles and rubella laboratory network (11, –, 13). This evidence concerns the gene CD40LG and measles.